An international group of scientists has identified 13 biomarkers to more accurately predict heart disease risk for people with Type 2 diabetes. The biomarkers, particularly N-terminal pro b-type natriuretic peptide (NT-proBNP), could help clinicians predict disease risk in a diverse population. Current risk scores are considered outdated. The study involved researchers at Johns Hopkins University, the Chinese University of Hong Kong, and Lund University in Sweden.
Seema Verma is ‘excited about progress’ of Oracle’s EHR modernization at VA
Seema Verma from Oracle Health updated on the VA’s Electronic Health Records Modernization at HIMSS25, highlighting increased patient satisfaction and ongoing challenges, including recent outages.
